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New information accrues periodically in the ledger accounting for infections and diseases
associated with the human enteroviruses. The discoveries of"new" serotypes and how they af-
fect people are subjects of continuing attention. Some other relevant information on "old"
serotypes relates to variations in age-specific attack rates and associated morbidity and mor-
tality for neonates and older infants. Among the morbidity reports are recounts during out-
breaks of virus-positive cerebrospinal fluids (CSFs) that initially may not have cytological or
biochemical abnormalities. Prolonged enterovirus infections may develop in persons having
agammaglobulinemia. Lastly, some provocative associations concern the pathologic expres-
sions of enteroviruses in the development and persistence of injury to the heart (myocardio-
pathies) and the pancreas (insulin-dependent diabetes mellitus).
NEW ACQUAINTANCES
The earliest classification of the enteroviruses as polio-, coxsackie, and/or echo-
viruses has been retained. However, overlapping properties provide difficulties in
assigning new serotypes to any one of the sub-groups. Hence new serotypes begin-
ning with Fermon (Enterovirus type 68) have been assigned sequential numbers.
Enterovirus 70
This serotype, responsible for widespread pandemics [1] and constricted focal
outbreaks ofhemorrhagic conjunctivitis (AHC), was established following recovery
of virus from conjunctival scrapings. The disease, characteristically expressed as an
ocular infection, occurs in densely populated communities, has high intrafamilial
spread, and involves adults more than children. The epidemiologic data indicate eye-
hand-vehicular (towels, etc.) modes of transmission.
Appearing first in central Africa, the disease advanced to southeast Asia, and
Japan. Despite people migrating from epidemic areas, outbreaks of AHC remained
unidentified in the Western Hemisphere until 1981 when outbreaks of AHC oc-
curred in Latin America, in Florida, and in North Carolina [2].
Wadia et al. [3] reported 19 adults (16 males) developing lumbosacral radiculo-
myelitis two to three weeks after onset of AHC. Motor paralysis (quadramono-
plegias) developed in 29 adults during an outbreak in Bangkok. The association was
based largely on the development of specific antibodies. Enterovirus 70 was seldom
if ever recovered from cerebrospinal fluids; occasionally E-70 was detected in fecal
specimens.
Monkeys inoculated intraspinally and intrathalamically with E-70 developed le-
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sions in the central nervous system (CNS) similar to those observed for attenuated
polioviruses [4]. The disease in monkeys and the neurological findings in human be-
ings suggest that E-70 has neurotropic properties. Whether or not delayed onset
radiculomyelitis arises as a consequence of primary viral invasion or from immuno-
logical injury remains uncertain.
Sera obtained from domestic animals (cattle, sheep, goats, swine, etc.) in endemic
areas neutralize E-70 (titer values > 1:16). One interpretation of the data is that
E-70 represents a variant of a parent virus distributed widely in those animals.
Enterovirus 71
Schmidt et al. [5] recovered serologically related enteroviruses from 20 persons
(1969-1972). These viruses are unrelated to existing serotypes; they have been desig-
nated E-71. Sixteen of the 20 isolates (all except one from feces) were derived from
children less than 11 years of age. Affected persons had clinical evidence of menin-
gitis or encephalitis. A five-year-old boy died; E-71 was recovered from brain tissue.
Deibel et al. [6] recovered E-71 virus from patients having similar illnesses.
Since 1972, outbreaks of disease from E-71 have been reported from Sweden,
Japan, Australia, and Bulgaria [7,8]. The clinical features include meningitis, seg-
mental limb paralysis, bulbo-spinal dysfunction, and cutaneous lesions of the hand-
foot-mouth syndrome. The epidemic in Bulgaria (1974) mainly involved infants.
Most presented with theaseptic meningitis syndrome. Of451 patients, 100developed
flaccid paralysis or cranial nerve (N VII) palsy or bulbar dysfunction. Twenty-nine
of 61 patients (47.5 percent) with brain stem involvement died. Viruses recovered
from CNS tissues of 27 persons were identified as E-71.
Enterovirus 71 has a few notable biological properties. The onset and progress of
cell destruction in cultured monkey kidney cells varies; cytopathic alterations are less
pronounced in rhesus cells than in those derived from grivet or green African mon-
keys. The Bulgarian strain evokes in monkeys a disease resembling poliomyelitis both
clinically and pathologically. Lesions in suckling mice, cotton rats, and hamsters
(myositis, paralysis) resemble those of Group A coxsackieviruses.
ATTENDANT RISKS FOR INFANTS
Fatal infections from Group B coxsackieviruses and echoviruses types 3, 6, 9, 11,
14, 17, 19, and 31 occur in newborn infants [9]. Exceptional risks relate to concur-
rent infections in their mothers, to nosocomial events, and possibly to the infants'
inability to mount a proper defense response. Otherwise older infants and toddlers
may develop overt disease from echoviruses types 3, 6, 11, 16, 18, and 19, as well as
enterovirus 71. As a rule illness engendered by many ofthese viruses has been benign
(but see above for E-71); a substantial fraction is associated with fever, rashes, diar-
rhea, and respiratory illnesses [10,11,12]. Discrete signs of meningitis, even with
CNS involvement (i.e., detection of virus) may not be found [12]. The majority of
infections are subclinical. Specifically, total recognition is restricted, based on sick
infants brought to the clinic or those enrolled in family studies. In our study, specific
infections were identified primarily in tests done to rule out sepsis or purulent men-
ingitis. By the midpoint of the outbreak there was a larger clinical appreciation of
the prevailing "viral syndrome."
Has there been a shift in attack rates from school age children to susceptible in-
fants and toddlers? The answer to the query is not yet evident, except possibly for
some enteroviruses. A major obstacle is the paucity of data relating to immunologic
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conversions occurring during infancy and early childhood. Solid information for
some enteroviruses (e.g., E-9, etc.) reveals ready recruitment among family associ-
ates at risk, thereby resembling polioviruses. Others (e.g., B-3) appear to recruit less
extensively and with slower velocities of spread [13,14].
The studies cited above highlight that fraction ofthe population for which specific
illnesses apply. They fail to account for the low-key clinical episodes or silent infec-
tions ongoing particularly during outbreaks ofenterovirus disease. The relationships
between covert and overt infections are well-recognized; however, the true ratios of
disease and infection are restricted largely by lack of information on intra-epidemic
antibody conversion rates occurring during the period of infancy and early child-
hood. The real rates are further obscured when combined as they often are in five-
year-age spans.
ENTEROVIRUSES RECOVERED FROM "NORMAL"
CEREBROSPINAL FLUIDS (CSFs)
The recovery of enteroviruses present in "normal" CSFs is no longer an excep-
tional event. The first reports involved one or several persons from whom viruses
(echoviruses types 4, 6, and 9) were recovered in CSFs unaccompanied by pleocy-
tosis [15]. Later Wilfert et al. [16] recovered echovirus type 18 from 12 of57 (21 per-
cent) normal CSFs. Bacon and Sims [17] recovered echovirus type 19 from six of 16
(37 percent) such fluids. In our study [12], 22 of 41 (54 percent) normal CSFs were
culture-positive for either echoviruses (types 6 and 9) or Group B coxsackieviruses
(types 2 and 3). Many, but not all, ofthe virus-positive CSFs were obtained from in-
fants; six (27 percent) were found among children three to 15 years ofage. Although
all six were febrile, only two presented with signs of meningitis.
The detection of enteroviruses in "normal" CSFs obtained from sick infants and
children again points up obstacles to the correct clinical diagnoses. Signs ofmeningi-
tis may not be significant components of illness. The CSFs were obtained mainly to
exclude early onset bacterial meningitis. The large fractions of positive CSFs cited
above provide examples not only for erroneous incidence rates of meningitis, but
also of wrong age-specific attack rates reported for infants and young children.
ENTEROVIRUSES AND PERSISTENT INFECTIONS
Immunocompromised persons may react to enterovirus infections differently
from their normal peers. The available observations link these lingering infections
with gammaglobulinopathies; however, there may be recruitment of persons having
combined immunodeficiencies. Described first for the polioviruses, particularly
post-vaccination, there are now recounts involving specific enteroviruses; among
these are echoviruses type 9, 19, 24, 30, and 33 [18,19,20].
The onset of CNS signs of illness, particularly for polioviruses, where inoculation
time is known, may be prolonged (> 3 weeks), with an expanded risk of death and
atypical CNS inflammatory lesions. Visceral organs may be involved in dissemi-
nated infections; a dermatomyositis-like syndrome may occasionally intervene.
Persons developing poliomyelitis may have prolonged shedding of virus from gut
and pharynx; cerebrospinal fluids are virus-negative. In contrast, echoviruses may
linger in CSFs for months or years; they are not readily recovered from feces or
pharynx. In disseminated forms of infection (e.g., type 24) virus may be recovered
from many extraneural organs, including muscle. Dual virus infections have been
reported [20].
279HERBERT A. WENNER
The peculiar host-parasite relationships are not clearly understandable, since all
immunodeficient persons do not seem to have equal risks! An intact B-cell function
is undoubtedly essential for blocking access of virus into the CNS, possibly facili-
tating eradication once therein. The absence of immunoglobulins appears to be a
responsible factor in the development of the atypical inflammatory response. Im-
munosuppressed individuals developing persistent infections may have high risks
associated with histocompatibility alleles [20].
ENTEROVIRUSES AND MYOCARDIOPATHIES
Enteroviruses cause not only acute myocardiopathies, but also lingering injury
and chronic heart disease [21]. Lerner et al. [22] set criteria associating enterovirus
infections with myocardiopathies, ranging from high to low orders of risk. High
risks were noted for Group A, types 4 and 16, for Group B, types 1-5 coxsackie-
viruses, and for echoviruses types 9, 11, and 12.
Burch et al. [23] observed discrete focal interstitial myocarditis in 29 of 50 hearts
obtained at autopsy. Using appropriately conjugated specific sera raised against
Group B coxsackieviruses, immunofluorescent (IF) myocytes and/or histocytes were
found in scattered areas of the myocardia of 12 infants and young children. Other
less frequent signals of specific myocardial disease include the rescue of enterovi-
ruses from pericardial fluid and/or myocardial tissues.
Cynomolgus monkeys infected experimentally with coxsackieviruses Group B,
type 4, develop pericarditis, myocarditis, and endocarditis; there may be associated
injury to valvular leaflets and chordae tendinae [241. Myocardial and endocardial le-
sions contain multinucleated giant myocytes similar to Aschoff bodies. Viral anti-
gens were observed by IF within the perinuclear cytoplasm of myocardial fibers.
Myocardiopathies in mice develop after infection from coxsackieviruses
[25,26,27]. The kinds ofinjury vary according to age, sex, and cardiotropic potential
of the virus. Group A, type 9, and Group B, type 1, evoke mild focal lesions in adult
mice. Group B, types 3 and 4, cause severe injury in weanling mice, expressed as
pericarditis and myocardial necrosis worst in the left ventricles and interventricular
septa. The visceral pericardium and mural endocardium exhibit advancing fibrosis
within the months following infection. Valvular fibrosis has been noted [25]; similar
lesions may be observed with advancing age in control mice[27]. There is enduring
cardiac hypertrophy and myofibril scarring. Young mice force-exercised had a signi-
ficantly higher death rate (arrhythmias?) than infected mice not exercised.
The cardiac lesions developing in animal models experimentally infected with cox-
sackieviruses simulate those observed in fatal infections of human beings. In addi-
tion to the acute primary infection from which patients seem to recover, these car-
diotropic viruses may provide permanent cardiac injury. Latent damage to the
myocrdium prepares the way for lingering effects expressed by arrhythmia and car-
diac failure.
INSULIN-DEPENDENT DIABETES MELLITUS (IDDM)
IDDM develops in youth (mean age - 12 years). The disease evokes loss of beta
cells in the islets of Langerhans. Small lymphocytes and scattered polymorphonu-
clear cells infiltrate the injured islets, mainly in apposition to injured beta cells.
Compelling data [28,29,30] support the concept that viruses can injure the pan-
creas. Although other viruses [31] may be involved, the concern here relates to cox-
sackieviruses, particularly Group B strains. Some strains cause profound injury of
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exocrine and endocrine tissues of the murine pancreas, especially after consecutive
passages ofinfective pancreatic brei. The B-4 virus grown in cultured pancreatic islet
tissue produces injury restricted to beta cells. After selective destruction diabetes
develops upon passage of such cells in susceptible strains of mice. Similar findings
have been described for the encephalomyocarditis (EMC) virus.
Direct evidence of coxsackievirus-induced IDMM was obtained from a ten-year-
old succumbing after an influenza-like illness associated with diabetes. Many beta
cells of the pancreas were destroyed. Pancreatic tissue extracts yielded coxsackie-
virus, B-4. The virus recultured in sensitive islet cells (in vitro) produced diabetes
and the pathological sequences noted above in susceptible mice [32].
While there is not a uniform concensus that all IDDMs are caused by viruses, the
available evidence indicates strong associations. In tandem with the cellular injury,
antibodies are raised against islet cell cytoplasmic and surface membrane compo-
nents. Cell-mediated antibodies and cytotoxicity develop early after onset. Whether
or not these are linked to virus-induced injuries of cellular components is yet un-
known. Moreover, the relationship ofhigh risks associated with alleles linked to the
HLA complex and virus susceptibility is not clearly defined.
SUMMARY
A library of information has accrued for the human enteroviruses and their
association with infection and disease. For most of these viruses there are common
but sometimes variable threads of information relating to clinical spectra, patho-
genesis, epidemiology, and immunology. This paper cites several common and some
of the less common characteristics of enteroviruses in a variety of disease expres-
sions.
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